Data gathered: January 30
AI Stock Analysis - Zomedica (ZOM)
Analysis generated January 7, 2025. Powered by Chat GPT.
Zomedica Corp. is a veterinary health company focused on providing innovative diagnostics and therapeutic technologies for companion animals. The company aims to advance the quality of care provided to pets through well-developed products and services. Zomedica has been strategically expanding its portfolio, which has been reflected by a noticeable increase in its operations and outreach.
Stock Alerts - Zomedica (ZOM)
 |
Zomedica | January 10 Price is down by -5.8% in the last 24h. |
|
Zomedica | January 8 Price is down by -5.3% in the last 24h. |
|
Zomedica | January 7 Employee Rating is down by 2.1% over the last month. |
|
Zomedica | January 7 Business Outlook among employees is down by 3.3% over the last month. |
Alternative Data for Zomedica
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 16 | Sign up | Sign up | Sign up |
| Sentiment | 87 | Sign up | Sign up | Sign up |
| Webpage traffic | 34,000 | Sign up | Sign up | Sign up |
| Employee Rating | 90 | Sign up | Sign up | Sign up |
| Google Trends | 32 | Sign up | Sign up | Sign up |
| Patents | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 132 | Sign up | Sign up | Sign up |
| Facebook Followers | 8,541 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 35 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 131,079 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,393 | Sign up | Sign up | Sign up |
| Twitter Mentions | 73 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,530 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 64 | Sign up | Sign up | Sign up |
| Business Outlook | 86 | Sign up | Sign up | Sign up |
| Linkedin Employees | 131 | Sign up | Sign up | Sign up |
About Zomedica
Zomedica is a veterinary health company focused on meeting the needs of clinical veterinarians in ways that promote both patient and practice health.
| Price | $0.12 |
| Target Price | Sign up |
| Volume | 3,130,000 |
| Market Cap | $148M |
| Year Range | $0.12 - $0.18 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Drug Manufacturers |
In the news
 |
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health MarketJanuary 6 - Yahoo |
|
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and ProgesteroneDecember 22 - Yahoo |
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial OfficerDecember 19 - Finnhub |
|
Zomedica : Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Form 8 KDecember 19 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 7M | 1.9M | 5.1M | -6.7M | -5.8M | -0.007 |
| Q2 '24 | 6.1M | 1.8M | 4.4M | -24M | -23M | -0.024 |
| Q1 '24 | 6.3M | 2.1M | 4.1M | -9.2M | -8.8M | -0.010 |
| Q4 '23 | 7.3M | 2.3M | 5.1M | -22M | -20M | -0.010 |
| Q3 '23 | 6.3M | 2M | 4.4M | -490,000 | -950,000 | -0.001 |
Insider Transactions View All
| Klass Russell Kevin filed to buy 1,210,250 shares at $0.1. November 12 '24 |
| Klass Russell Kevin filed to buy 1,500,050 shares at $0.1. November 12 '24 |
| HEATON LARRY C II filed to buy 500,000 shares at $0.1. November 12 '24 |
| POWERS JOHNNY D filed to buy 2,425,000 shares at $0.1. November 12 '24 |
| Blair Anthony K filed to buy 400,000 shares at $0.1. November 13 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$152.87 1.1% | 49 |
 |
Eli Lilly and CompanyLLY |
$823.23 2.4% | 65 |
 |
PfizerPFE |
$26.91 1.1% | 38 |
 |
AstrazenecaAZN |
$71.24 1.4% | 48 |
 |
AbbVieABBV |
$175.65 0.2% | 51 |
Read more about Zomedica (ZOM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Zomedica?
The Market Cap of Zomedica is $148M.
What is the current stock price of Zomedica?
Currently, the price of one share of Zomedica stock is $0.12.
How can I analyze the ZOM stock price chart for investment decisions?
The ZOM stock price chart above provides a comprehensive visual representation of Zomedica's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zomedica shares. Our platform offers an up-to-date ZOM stock price chart, along with technical data analysis and alternative data insights.
Does ZOM offer dividends to its shareholders?
As of our latest update, Zomedica (ZOM) does not offer dividends to its shareholders. Investors interested in Zomedica should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Zomedica?
Some of the similar stocks of Zomedica are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.